Atrial fibrillation in patients with obesity: How can we optimize management?

Asim Kichloo; Ivan Magallanes Marrufo; Suhaib Andrabi

doi:10.3949/ccjm.93a.25032

January 1, 2026Cleveland Clinic Journal of MedicineOpen Access

Atrial fibrillation in patients with obesity: How can we optimize management?

View Full Paper

Ask AI

Bookmark

Share

Key result

Tailored rate and rhythm control alongside comprehensive preventive measures optimize AF management in obese patients.

Why the study?

How can we optimize management of atrial fibrillation in patients with obesity?

Key Points

To review therapeutic adjustments and risk factor interventions required to optimize heart rate and rhythm management in patients with obesity and atrial fibrillation.
Synthesized clinical trial data and guidelines regarding heart rate control, rhythm control via cardioversion and catheter ablation, stroke prophylaxis, and risk factor modification.
Obesity increases new-onset atrial fibrillation risk by 50%, with each 5-unit increase in body mass index (BMI) raising atrial fibrillation incidence by 30%.
Class I obesity (BMI 30-34.9 kg/m²) and class II obesity (BMI 35.0-39.9 kg/m²) are associated with a 54% and 87% higher risk, respectively, of progressing from paroxysmal to permanent atrial fibrillation.
In an evaluation of 148 randomized controlled trials of catheter ablation, 97.3% did not report obesity prevalence and only 63.5% reported BMI.

Structured PICO

How can we optimize management of atrial fibrillation in patients with obesity?

P

Population

Patients with obesity and atrial fibrillation

I

Intervention

Multifaceted management including weight loss, bariatric surgery, obstructive sleep apnea screening and treatment, botulinum toxin injection into epicardial fat pads, glucagon-like peptide 1 (GLP-1) receptor agonists, sodium-glucose cotransporter 2 (SGLT-2) inhibitors, and tailored cardioversion and anticoagulation

Optimizing atrial fibrillation management in patients with obesity requires a comprehensive approach addressing weight loss, sleep apnea, tailored procedural techniques, and adjunctive metabolic pharmacotherapy.

Limitations

Lack of BMI-based stratification in randomized controlled trials of catheter ablation may bias outcomes and obscure treatment efficacy across weight groups

Implication

May support tailored AF strategies in obesity; leaves open confirmation of outcome benefits in prospective trials.

Abstract

Heart rate and rhythm control therapies often must be adjusted when treating patients with obesity, while other measures can reduce the onset or recurrence of atrial fibrillation.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kichloo et al. (2026) studied this question. Optimizing management of atrial fibrillation in obese patients requires adjusting heart rate and rhythm control therapies and implementing preventive measures.

synapsesocial.com/papers/696321ef91e05aa366cb83d4 https://doi.org/10.3949/ccjm.93a.25032

View Full Paper

Ask AI

Bookmark

Share

Atrial fibrillation in patients with obesity: How can we optimize management?

Key Points

Structured PICO

Limitations

Implication

Abstract

Discussion

Cite This Study

Atrial fibrillation in patients with obesity: How can we optimize management?

Key Points

Structured PICO

Limitations

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading